DE502007003888D1 - Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung - Google Patents

Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung

Info

Publication number
DE502007003888D1
DE502007003888D1 DE502007003888T DE502007003888T DE502007003888D1 DE 502007003888 D1 DE502007003888 D1 DE 502007003888D1 DE 502007003888 T DE502007003888 T DE 502007003888T DE 502007003888 T DE502007003888 T DE 502007003888T DE 502007003888 D1 DE502007003888 D1 DE 502007003888D1
Authority
DE
Germany
Prior art keywords
solid
aqueous alkaline
alkaline preparation
production
creatine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE502007003888T
Other languages
English (en)
Inventor
Thomas Gastner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alzchem Trostberg GmbH
Original Assignee
Alzchem Trostberg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38980980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE502007003888(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alzchem Trostberg GmbH filed Critical Alzchem Trostberg GmbH
Publication of DE502007003888D1 publication Critical patent/DE502007003888D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
DE502007003888T 2006-10-28 2007-10-26 Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung Active DE502007003888D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006050931A DE102006050931A1 (de) 2006-10-28 2006-10-28 Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
PCT/EP2007/009324 WO2008052712A1 (de) 2006-10-28 2007-10-26 Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
DE502007003888D1 true DE502007003888D1 (de) 2010-07-01

Family

ID=38980980

Family Applications (2)

Application Number Title Priority Date Filing Date
DE102006050931A Ceased DE102006050931A1 (de) 2006-10-28 2006-10-28 Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
DE502007003888T Active DE502007003888D1 (de) 2006-10-28 2007-10-26 Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE102006050931A Ceased DE102006050931A1 (de) 2006-10-28 2006-10-28 Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung

Country Status (11)

Country Link
US (1) US20100056633A1 (de)
EP (1) EP2094116B1 (de)
JP (1) JP5590889B2 (de)
AT (1) ATE468030T1 (de)
CA (1) CA2667667C (de)
DE (2) DE102006050931A1 (de)
DK (1) DK2094116T3 (de)
ES (1) ES2341910T3 (de)
PL (1) PL2094116T3 (de)
SI (1) SI2094116T1 (de)
WO (1) WO2008052712A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
DE102007062288A1 (de) 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
WO2010078322A1 (en) * 2008-12-30 2010-07-08 Hill's Pet Nutrition, Inc. Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals
AU2010234206B2 (en) * 2009-04-06 2016-10-27 Crearene Ag Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
AU2014280235B2 (en) 2013-06-12 2019-10-03 Anabio Technologies Limited A process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell
JP6991445B2 (ja) 2016-09-06 2022-02-03 地方独立行政法人青森県産業技術センター アルギニンを豊富に含有する多糖

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322407A (en) * 1978-12-11 1982-03-30 Vitapharm Pharmaceutical Pty. Ltd. Electrolyte drink
US5151274A (en) * 1990-08-06 1992-09-29 The Procter & Gamble Company Calcium and trace mineral supplements
US5318784A (en) * 1992-09-09 1994-06-07 Amurol Products Company Pourable chewing gum and confection composition
US5908864A (en) * 1998-05-28 1999-06-01 Dymatize Enterprises Creatine gel
DE19830768A1 (de) * 1998-07-09 2000-01-13 Sueddeutsche Kalkstickstoff Kreatin-enthaltende Formulierung und Verfahren zu deren Herstellung
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6114379A (en) * 1999-07-07 2000-09-05 Albion Laboratories, Inc. Bioavailable chelates of creatine and essential metals
WO2001089476A1 (en) * 2000-05-19 2001-11-29 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US6399661B1 (en) * 2000-06-26 2002-06-04 Jeffrey M. Golini Oral creatine supplement and method for making same
ATE341948T1 (de) * 2001-03-02 2006-11-15 Howard Foundation Zusammensetzung enthaltend kreatin und kreatinin
DE10215007A1 (de) * 2002-04-05 2003-10-16 Degussa Bioactives Deutschland Verwendung von Kreatinpyruvat zur Steigerung der Ausdauer bei hochintensiven körperlichen Intervallbelastungen
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement
GB0323240D0 (en) * 2003-10-03 2003-11-05 Golini Jeffrey M Creatine composition and use
RU2341972C2 (ru) * 2004-06-09 2008-12-27 Альцхем Тростберг Гмбх Применение гуанидинуксусной кислоты в качестве кормовой добавки
EP2023718A4 (de) * 2006-05-11 2010-04-21 Avicena Group Inc Kreatinligandverbindungen und anwendungsverfahren dafür

Also Published As

Publication number Publication date
DK2094116T3 (da) 2010-09-06
US20100056633A1 (en) 2010-03-04
ES2341910T3 (es) 2010-06-29
EP2094116A1 (de) 2009-09-02
ATE468030T1 (de) 2010-06-15
CA2667667C (en) 2014-09-09
DE102006050931A1 (de) 2008-04-30
WO2008052712A1 (de) 2008-05-08
CA2667667A1 (en) 2008-05-08
SI2094116T1 (sl) 2010-09-30
JP5590889B2 (ja) 2014-09-17
JP2010508249A (ja) 2010-03-18
EP2094116B1 (de) 2010-05-19
PL2094116T3 (pl) 2010-10-29

Similar Documents

Publication Publication Date Title
DE502007003888D1 (de) Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
DK1758463T3 (da) Guanidinoeddikesyre som fodermiddeltilsætning
WO2009079910A8 (zh) 促红细胞生成素模拟肽衍生物及其可药用盐和其制备方法与用途
DE112006003526A5 (de) Carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung
IL184504A (en) Combined Salts of 4- (2, 6-Dichlorobenzoylamino) h 1-Pyrosol-3-Carboxylic Acid Piperidine-4-Illamide, Methods of Preparation and Pharmaceutical Preparations and Liquid Solutions
WO2007057678A3 (en) Pathogen - controlling products
ATE425961T1 (de) Salze substituierter allophansaureester und deren verwendung in arzneimitteln
UA89827C2 (ru) Стабильный активный комплекс соли о-ацетилсалициловой кислоты с основными аминокислотами и глицином
WO2009098191A3 (en) Method to produce hyperpolarised amino acids and aminosulphonic acids
GEP20135800B (en) Method of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives preparation
IL266097A (en) Citric acid acid salt of (R)-5-((E)-2-(pyrrolidine-3-yl)vinyl)pyrimidine, a pharmaceutical preparation containing the salt, use of the salt in the production of a medicine, salt for use, and method of production
BRPI0812321A2 (pt) Sais de ácido etilenodiamina dissuccínico, composição contendo os ditos sais, uso e método de preparação destes.
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
WO2009090439A3 (en) Method for stabilization of s-nitrosoglutathione and composition prepared by the same
DE50103606D1 (de) Mittel zur färbung von fasern
DE602006001947D1 (de) Verfahren zur aufreinigung von thioctansäure in wasser
EP1767090A4 (de) Clathratverbindung, verfahren zur überprüfung der konzentration einer wässrigen lösung eines agrarchemikalienwirkstoffs, sowie herstellung von agrarchemikalien
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
ATE512134T1 (de) Verfahren zur herstellung von 5-benzyloxy-2-(4- benzyloxyphenyl)-3-methyl-1h-indol
TW200635613A (en) Water-soluble cosmetic composition and method for manufacturing the same
BRPI0909752B8 (pt) processos para a produção de sulfonilpirróis como inibidores de hdac e de uma composição farmacêutica compreendendo os mesmos
WO2007071649A3 (de) Salze der styphninsäure
NO20033707L (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr
NO20033706D0 (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr

Legal Events

Date Code Title Description
8363 Opposition against the patent